Michael David

Michael David

Auto-generated profile, based on publicly available information

Michael David

The Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, NSW, Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2025 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
RSRicha Shah
Richa Shah
NHNader Hanna
Nader Hanna
CLChing Ee Loo
Ching Ee Loo
MDMichael David
Michael David
AMAllini Mafra
Allini Mafra
ISIsabelle Soerjomataram
Isabelle Soerjomataram


1 February 2015 in Burns
Verified
Journal Article
Closed access
KSK.A. Stockton
K.A. Stockton
CMC.M. McMillan
C.M. McMillan
KSK.J. Storey
K.J. Storey
MDM.C. David
M.C. David
RKRoy Kimble
Roy Kimble

1 May 2013 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
MDMichael C. David
Michael C. David
RARosa Alati
Rosa Alati
Robert WareRobert Ware
Robert Ware
SKStuart A. Kinner
Stuart A. Kinner

1 November 2015 in Vaccine
Verified
Journal Article
Closed access
MDMichael C. David
Michael C. David
SHSung Hyun Ha
Sung Hyun Ha
SPStuart Paynter
Stuart Paynter
Colleen LauColleen Lau
Colleen Lau

10 September 2024 in Australian and New Zealand Journal of Public Health
Verified
Journal Article
Open access
SESam Egger
Sam Egger
MDMichael David
Michael David
CWChristina Watts
Christina Watts
ADAnita Dessaix
Anita Dessaix
ABAlecia Brooks
Alecia Brooks
BFBecky Freeman
Becky Freeman
The objective of this study was to estimate the association between vaping and subsequent initiation of smoking among Australian adolescents and explore the impact of design and analytical methods in previous studies. We conducted a retrospective cohort analysis of cross-sectional data from 5114 Australian adolescents aged 14-17 recalling information on smoking and vaping initiation from age 12 to 17. The outcome was smoking initiation, analysed with negative-binomial regression to estimate incidence rate ratios (IRRs) for vape status (ever-vaped vs never-vaped) as a time-varying exposure. We also re-analysed using the methods of previous studies not accounting for the time-varying nature of e-cigarette exposure. Participants (n=5114) were retrospectively followed for 20478 person-years. After adjusting for socio-demographic variables and proxy measures of common liabilities for vaping and smoking, the rate of smoking initiation for those who ever-vaped was nearly 5 times that of those who never-vaped (IRR=4.9; 95% confidence interval: [3.9, 6.0], p<0.001), with IRRs considerably higher at younger ages. Not accounting for the time-varying nature of e-cigarette exposure in re-analysis attenuated the estimated IRR by 44%. Controlled analyses indicate that vaping markedly increases the risk of subsequent smoking initiation among Australian adolescents from age 12 to 17, with those aged 12, 13, and 14 bearing an alarmingly disproportionate burden of the elevated risk. Additionally, the relative risk of future smoking due to vaping may have been underestimated in other studies due to methodological differences. Our findings highlight the need for public health interventions and strict e-cigarette access laws.